Tuberculosis in the European Region.

IF 3.6 Q2 INFECTIOUS DISEASES

Current Tropical Medicine Reports Pub Date : 2023-05-27 DOI:10.1007/s40475-023-00287-8

Jessica Mencarini, Michele Spinicci, Lorenzo Zammarchi, Alessandro Bartoloni

{"title":"Tuberculosis in the European Region.","authors":"Jessica Mencarini, Michele Spinicci, Lorenzo Zammarchi, Alessandro Bartoloni","doi":"10.1007/s40475-023-00287-8","DOIUrl":null,"url":null,"abstract":"Purpose of review: Tuberculosis (TB) remains a major public health concern worldwide. The COVID-19 pandemic and migration flow due to socioeconomic conditions, climate change, and geopolitical issues, such as the war, are important drivers influencing TB epidemiology in Europe. This article aims to review the data about TB in this area and the new findings about treatment and prevention strategies.Recent findings: During the COVID-19 pandemic, access to health facilities and retention in care were difficult for TB patients, with consequences on TB diagnosis and TB incidence. The ongoing conflict in Europe, in areas with high prevalence of TB and MDR-TB, has reduced the access to health services and the availability of anti-TB drugs and increased the migration of refugees. New data on short treatment regimens could change the length of therapy and adverse events.Summary: TB control programs are facing emerging challenges that could change TB incidence in the near future. Novel antibiotic strategies and improved preventive policies could offer new opportunities to reduce the TB impact on public health.","PeriodicalId":37441,"journal":{"name":"Current Tropical Medicine Reports","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2023-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220343/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Tropical Medicine Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40475-023-00287-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 2

Abstract

Purpose of review: Tuberculosis (TB) remains a major public health concern worldwide. The COVID-19 pandemic and migration flow due to socioeconomic conditions, climate change, and geopolitical issues, such as the war, are important drivers influencing TB epidemiology in Europe. This article aims to review the data about TB in this area and the new findings about treatment and prevention strategies.

Recent findings: During the COVID-19 pandemic, access to health facilities and retention in care were difficult for TB patients, with consequences on TB diagnosis and TB incidence. The ongoing conflict in Europe, in areas with high prevalence of TB and MDR-TB, has reduced the access to health services and the availability of anti-TB drugs and increased the migration of refugees. New data on short treatment regimens could change the length of therapy and adverse events.

Summary: TB control programs are facing emerging challenges that could change TB incidence in the near future. Novel antibiotic strategies and improved preventive policies could offer new opportunities to reduce the TB impact on public health.

查看原文本刊更多论文

欧洲地区的肺结核。

审查目的：结核病仍然是全世界关注的主要公共卫生问题。由于社会经济条件、气候变化和战争等地缘政治问题，新冠肺炎大流行和移民流动是影响欧洲结核病流行病学的重要驱动因素。本文旨在回顾该领域有关结核病的数据以及有关治疗和预防策略的新发现。最近的研究结果：在新冠肺炎大流行期间，结核病患者很难获得卫生设施和继续接受治疗，这对结核病诊断和结核病发病率产生了影响。欧洲结核病和耐多药结核病高发地区的持续冲突减少了获得卫生服务的机会和抗结核病药物的供应，并增加了难民的移民。关于短期治疗方案的新数据可能会改变治疗时间和不良事件。综述：结核病控制项目正面临新的挑战，这些挑战可能在不久的将来改变结核病的发病率。新的抗生素战略和改进的预防政策可以为减少结核病对公共卫生的影响提供新的机会。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Tropical Medicine Reports Medicine-Infectious Diseases

CiteScore

9.30

自引率

1.90%

发文量

期刊介绍： Current Tropical Medicine Reports provides expert views on recent advances in the field of tropical medicine in a clear and readable form. This journal offers reviews by domestic and international contributors that highlight the most important, recent papers and findings related to this specific field. We accomplish this by appointing renowned leaders in major tropical medicine subject areas to select topics addressing virology, bacteriology, parasitology, entomology, immunology, cell and molecular biology, epidemiology, ecology, behavioral science and clinical medicine for review by experts who assess the latest developments and highlight significant papers published over the last few years on their topics. These review articles also stress recently published papers of importance in the references, which are accompanied by annotations explaining their importance. In addition to these Section Editors, our international Editorial Board ensures our journal upholds its standards.